The Lancet: March 07, 2008

In this week's podcast, Martin Bachmann discusses results of a phase II study showing how a vaccine to inhibit angiotensin II is safe and well tolerated; the vaccine also shows promising results in reducing blood pressure for people with hypertension. Authors of a Comment state: "Vaccination for hypertension may turn out to be very useful in many patients."Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://faceboo...